BDTX Company Profile and Key Details

Q: Who are the executives of BDTX?

Dr. Christopher D. Roberts Ph.D.AdvisorDr. Elizabeth Buck Ph.D.Co-Founder & Chief Scientific OfficerMr. Brent Hatzis-Schoch Esq., J.D.Chief Operating Officer & Gen. CounselMs. Melanie MorrisonChief Devel. OfficerMr. Tai-An Lin Ph.D.Senior Vice President of Translational Science & Discovery BiologyDr. Sergey Yurasov M.D., Ph.D.Chief Medical OfficerDr. Fang Ni Pharm.D.Chief Financial Officer, Principal Financial Officer and Chief Bus. OfficerMs. Elizabeth L. MontgomeryChief People OfficerDr. David M. Epstein Ph.D.Co-Founder, Pres, Chief Executive Officer & DirectorMs. Erika JonesVice President of Fin., Corporation Controller & Principal Accounting Officer

NASDAQ : BDTX

Black Diamond Therapeutics

$1.69

-0.025-1.46%

At Close 4:00 PM

63.99

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Black Diamond Therapeutics, Inc. (BDTX) stock declined over -1.46%, trading at $1.69 on NASDAQ, down from the previous close of $1.72. The stock opened at $1.71, fluctuating between $1.62 and $1.71 in the recent session.

Stock Snapshot

1.715

Prev. Close

96.84M

Market Cap

1.62

Day Low

-2.64

P/E Ratio

-0.64

EPS (TTM)

-1.29

Cash Flow per Share

1.71

Open

57.3M

Number of Shares

1.71

Day High

68.91%

Free Float in %

2.26

Book Value

619.6K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 31, 2026	1.71	1.71	1.62	1.69	622.86K
Jul 30, 2026	1.68	1.72	1.65	1.72	536.13K
Jul 29, 2026	1.76	1.78	1.64	1.66	869.44K
Jul 28, 2026	1.76	1.77	1.69	1.76	1.06M
Jul 27, 2026	1.77	1.85	1.73	1.73	625.1K
Jul 24, 2026	1.83	1.83	1.75	1.76	623.04K
Jul 23, 2026	1.81	1.85	1.80	1.84	522.38K
Jul 22, 2026	1.86	1.90	1.81	1.83	519.33K
Jul 21, 2026	1.82	1.88	1.78	1.87	489.37K
Jul 20, 2026	1.82	1.86	1.77	1.81	695.82K
Jul 17, 2026	1.78	1.87	1.78	1.79	708.17K
Jul 16, 2026	1.78	1.82	1.76	1.81	855.75K
Jul 15, 2026	1.85	1.88	1.78	1.81	837.89K
Jul 14, 2026	1.89	1.94	1.85	1.86	609.49K
Jul 13, 2026	1.89	1.98	1.83	1.90	828.54K
Jul 10, 2026	1.92	1.94	1.81	1.91	1.05M
Jul 09, 2026	1.92	1.95	1.87	1.88	762.32K
Jul 08, 2026	2.04	2.10	1.90	1.90	1.76M
Jul 07, 2026	1.97	2.22	1.94	2.08	2.2M
Jul 06, 2026	2.01	2.07	1.93	1.97	1.79M

Contact Details

Cambridge, MA 02142

United States

https://www.blackdiamondtherapeutics.com 617 252 0848

About Company

Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) driver mutations. The firm is also progressing BDTX-1535, a brain-penetrant inhibitor addressing a range of EGFR mutations, including conventional, inherent resistance, and acquired resistance forms. Concurrently, it is advancing BDTX-4933, another brain-penetrant inhibitor targeting oncogenic BRAF alterations across Class I, II, and III categories. Black Diamond maintains a strategic alliance with OpenEye Scientific Software, Inc. Established in 2014, the company was initially known as ASET Therapeutics, Inc. before adopting its current name, Black Diamond Therapeutics, Inc., in January 2018. Its corporate headquarters are situated in Cambridge, Massachusetts.

Stock Peers

ARGX

-18.76-2.15%

argenx SE$853.82 REGN

24.29+3.29%

Regeneron Pharmaceuticals, Inc.$762.63 UTHR

-8.11-1.54%

United Therapeutics Corporation$517.71 VRTX

-4.6-0.95%

Vertex Pharmaceuticals Incorporated$477.10 MDGL

-25.79-5.23%

Madrigal Pharmaceuticals, Inc.$467.32 KRYS

-25.73-7.01%

Krystal Biotech, Inc.$341.12 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

-6.07-1.88%

BeOne Medicines AG$316.01 PRAX

0.08+0.03%

Praxis Precision Medicines, Inc.$307.83 LGND

-8.75-2.95%

Ligand Pharmaceuticals Incorporated$287.54

Frequently Asked Questions

What is the current Black Diamond Therapeutics, Inc. (BDTX) stock price?

Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) stock price is $1.69 in the last trading session. During the trading session, BDTX stock reached the peak price of $1.71 while $1.62 was the lowest point it dropped to. The percentage change in BDTX stock occurred in the recent session was -1.46% while the dollar amount for the price change in BDTX stock was - $0.03.

BDTX's industry and sector of operation?

The NASDAQ listed BDTX is part of Biotechnology industry that operates in the broader Healthcare sector. Black Diamond Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BDTX?

Dr. Christopher D. Roberts Ph.D.
Advisor
Dr. Elizabeth Buck Ph.D.
Co-Founder & Chief Scientific Officer
Mr. Brent Hatzis-Schoch Esq., J.D.
Chief Operating Officer & Gen. Counsel
Ms. Melanie Morrison
Chief Devel. Officer
Mr. Tai-An Lin Ph.D.
Senior Vice President of Translational Science & Discovery Biology
Dr. Sergey Yurasov M.D., Ph.D.
Chief Medical Officer
Dr. Fang Ni Pharm.D.
Chief Financial Officer, Principal Financial Officer and Chief Bus. Officer
Ms. Elizabeth L. Montgomery
Chief People Officer
Dr. David M. Epstein Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Ms. Erika Jones
Vice President of Fin., Corporation Controller & Principal Accounting Officer

How BDTX did perform over past 52-week?

BDTX's closing price is 5.62% higher than its 52-week low of $1.60 where as its distance from 52-week high of $4.94 is -65.79%.

How many employees does BDTX have?

Number of BDTX employees currently stands at 21.

Link for BDTX official website?

Official Website of BDTX is: https://www.blackdiamondtherapeutics.com

How do I contact BDTX?

BDTX could be contacted at phone 617 252 0848 and can also be accessed through its website. BDTX operates from 245 First Street, Cambridge, MA 02142, United States.

How many shares of BDTX are traded daily?

BDTX stock volume for the day was 619.6K shares. The average number of BDTX shares traded daily for last 3 months was 1.72M.

What is the market cap of BDTX currently?

The market value of BDTX currently stands at $96.84M with its latest stock price at $1.69 and 57.3M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	21
Beta	3.25
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	21
Beta	3.25
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

BDTX Company Profile and Key Details

Black Diamond Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook